Hypothesis: The role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension

Kidney International

Volumn 52, Issue 5, 1997, Pages 1169-1179

  Johnson, Richard J ^a   Schreiner, George F ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b NONE

Author keywords

Adenosine; Hypertension; Nitric oxide; Osteopontin; Pressure natriuresis; Renal medulla; Salt; Tubuloglomerular feedback

Indexed keywords

ADENOSINE; ALDOSTERONE; ANGIOTENSIN; CATECHOLAMINE; DOPAMINE; NITRIC OXIDE; PROSTAGLANDIN; SODIUM CHLORIDE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DISEASE COURSE; ESSENTIAL HYPERTENSION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY TUBULE DAMAGE; NEGRO; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT INTAKE; SYMPATHETIC NERVE;

EID: 0030667865     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.442     Document Type: Article

References (135)

1. COWLEY A, ROMAN R: The role of the kidney in hypertension. JAMA 275:1581-1589, 1996
2. DE WARDENER HE: The primary role of the kidney and salt intake in the aetiology of essential hypertension: Part 1 (see comments). Clin Sci Colch 79:193-200, 1990
3. LIFTON R: Molecular genetics of human blood pressure variation. Science 272:676-680, 1996
4. SHIMKETS R, WARNOCK D, BOSTTIS C, NELSON-WILLIAMS C, HANSSON JH, SCHAMBELAN M, GILL JR JR., ULICK S, MILORA RV, FINDLING JW, CANESSA CM, ROSSIER BC, LIFTON RP: Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79:407-414, 1994
5. WEINBERGER MH: Salt sensitivity of blood pressure in humans. Hypertension 27(3 Pt 2):481-90, 1996
6. MIDGLEY JP, MATTHEW AG, GREENWOOD CM, LOGAN AG: Effect of reduced dietary sodium on blood pressure: A meta-analysis of randomized controlled trials (see+ comments). JAMA 275:1590-1597, 1996
7. WEDLER G, BRIER M, WIERSBITSKY M, GRUSKA S, WOLF E, KALLWELLIS R, ARONOFF GR, LUFT FC: Sodium kinetics in salt-sensitive and salt-resistant normotensive and hypertensive subjects. J Hypertens 10:663-669, 1992
8. GILL J JR, GULLNER H, LAKE C, LAKATUA D, LAN G: Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 11:312-319, 1988
9. WEINBERGER M, FINEBERG N: Sodium and volume sensitivity of blood presure: Age and pressure change over time. Hypertension 18:67-71, 1991
10. JULIUS S: The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension. Clin Exp Hypertens 18:305-321, 1996
11. JULIUS S: Transition from high cardiac output to elevated vascular resistance in hypertension. Am Heart J 116(2 Pt 2):600-606, 1988
12. DEGAUTE JP, VAN DE BORNE P, LINKOWSKI P, VAN CAUTER E: Quantitative analysis of the 24-hour blood pressure and heart rate patterns in young men (see comments). Hypertension 18:199-210, 1991
13. BLVAN AT, HONOUR AJ, STOTT FH: Direct arterial pressure recording in unrestricted man. Clin Sci 36:329-344, 1969
14. KAPLAN N: Clinical Hypertension (5th ed). Baltimore, Williams & Wilkins, 1994
15. LEVY R, HILLMAN C, STROUD W, WHITE P: Transient hypertension: Its significance in terms of later development of sustained hypertension and cardiovascular-renal disease. JAMA 126:829-833, 1944
16. WILSON NV, MEYER BM: Early prediction of hypertension using exercise blood pressure. Prev Med 10:62-68, 1981
17. BROOKS D, HORNER RL, KOZAR LF, RENDER TEIXEIRA CL, PHILLIPSON EA: Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model (see comments). J Clin Invest 99:106-109, 1997
18. JULIUS S, SCHORK MA: Predictors of hypertension. Ann NY Acad Sci 304:38-58, 1978
19. WEBER MA, NEUTEL JM, SMITH DH, GRAETTINGER WF: Diagnosis of mild hypertension by ambulatory blood pressure monitoring (see comments). Circulation 90:2291-2298, 1994
20. WATSON RD, STALLARD TJ, FLINN RM, LITTLER WA: Factors determining direct arterial pressure and its variability in hypertensive man. Hypertension 2:333-341, 1980
21. JAMES GD, PICKERING TG, LARAGH JH: Ambulatory blood pressure variation is related to plasma renin activity in borderline hypertensive men. Am J Hypertens 4:525-528, 1991
22. DIBONA G, KOPP U: Neural control of renal function. Physiol Rev 77:75-197, 1997
23. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV YV, ET AL: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
24. NAVAR LG: Renal autoregulation: Perspectives from whole kidney and single nephron studies. Am J Physiol 234:F357-F370, 1978
25. HEYERASS TONDER K, AUKLAND K: Interlobular arterial pressure in the rat kidney. Renal Physiol 2:214-221, 1979/80
26. NAVAR LG, BELL PD, BURKE TJ: Autoregulatory responses of superficial nephrons and their association with sodium excretion during arterial pressure alterations in the dog. Circ Res 41:487-496, 1977
27. SCHNERMANN J, BRIGGS JP: The role of adenosine in cell-to-cell signaling in the juxtaglomerular apparatus. Semin Nephrol 13:236-245, 1993
28. SCHNERMANN J, BRIGGS J: Effect of angiotensin and other pressor agents on tubuloglomerular feedback responses. Kidney Int 38(Suppl 30):S77-S80, 1990
29. WILCOX C, WELCH W, MURAD F, GROSS SS, TAYLOR G, LEVI R, SCHMIDT HH: Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 89:11993-11997, 1992
30. SCHNERMANN J, TODD K, BRIGGS J: Effect of dopamine on the tubuloglomerular feedback mechanism. Am J Physiol 258:F790-F798, 1990
31. BRIGGS J, SCHNERMANN J: Whys and wherefores of juxtaglomerular apparatus function. Kidney Int 49:1724-1726, 1996
32. MCCOY DE, BHATTACHARYA S, OLSON BA, LEVIER DG, AREND LJ, SPIELMAN WS: The renal adenosine system: Structure, function, and regulation. Semin Nephrol 13:31-40, 1993
33. STOOS B, GARCIA N, GARVIN J: Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol 6:89-94, 1995
34. COGAN M: Angiotensin II: A powerful controller of sodium transport in the early proximal tubule. Hypertension 15:451-458, 1990
35. GUYTON AC, COLEMAN TG, COWLEY AV JR, SCHEEL KW, MANNING RD JR, NORMAN RA JR: Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52:584-594, 1972
36. COWLEY AW JR, MATTSON DL, LU S, ROMAN RJ: The renal medulla and hypertension. Hypertension 25(4 Pt 2):663-673, 1995
37. ROMAN RJ: Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats. Am J Physiol 251(1 Pt 2):F57-F65, 1986
38. ROMAN RJ, COWLEY AW JR, GARCIA ESTAN J, LOMBARD JH: Pressure-diuresis in volume-expanded rats. Cortical and medullary hemodynamics. Hypertension 12:168-176, 1988
39. ROMERO JC, KNOX FG: Mechanisms underlying pressure-related natriuresis: The role of the renin-angiotensin and prostaglandin systems. State of the art lecture. Hypertension 11(6 Pt 2):724-738, 1988
40. GRANGER JP: Pressure natriuresis. Role of renal interstitial hydrostatic pressure. Hypertension 19(1 Suppl):19-117, 1992
41. ROMAN RJ: Pressure-diuresis in volume-expanded rats. Tubular reabsorption in superficial and deep nephrons. Hypertension 12:177-183, 1988
42. SONNENBERG H, HONRATH U, WILSON DR: Effects of increased perfusion pressure on medullary collecting duct function. Can J Physiol Pharmacol 68:402-407, 1990
43. AZAR S, TOBIAN L, JOHNSON MA: Glomerular, efferent arteriolar, peritubular capillary, and tubular pressures in hypertension. Am J Physiol 227:1045-1050, 1974
44. MYERS BD, DEEN WM, BRENNER BM: Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37:101-110, 1975
45. HALL J, GRANGER J, HESTER R, COLEMAN T, SMITH MJ, CROSS R: Mechanisms of escape from sodium retention during angiotensin II hypertension. Am J Physiol 246:F627-F634, 1984
46. MAJID D, NAVAR LG: Medullary blood flow responses to changes in arterial pressure in canine kidney. Am J Physiol 270:F833-F838, 1996
47. MENDELSOHN FA, DUNBAR M, ALLEN A, CHOU ST, MILLAN MA, AGUILERA G, CATT KJ: Angiotensin II receptors in the kidney. Fed Proc 45:1420-1425, 1986
48. FAUBERT PF, CHOU SY, PORUSH JG: Regulation of papillary plasma flow by angiotensin II. Kidney Int 32:472-478, 1987
49. BOHLE A, MULLER G, WEHRMANN M, MACKENSEN-HAEN S, XIAO J-C: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int 49(Suppl 54):S2-S9, 1996
50. RATSCHEK M, RATSCHEK E, BOHLE A: Decompensated benign nephrosclerosis and secondary malignant nephrosclerosis. Clin Nephrol 25:221-226, 1986
51. KRIZ W, ELGER M, MUNDEL P, LEMLEY K: Structure-stabilizing forces in the glomerular tuft, (editorial) J Am Soc Nephrao 5:1731-1739, 1995
52. ANDERSON S, MEYER T, RENNKE H, BRENNER B: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
53. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZL P, FLOEGE J, SCHWARTZ SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
54. THOMAS SE, ANDERSON S, GORDONKL, OYAMA TT, SHANKLAND SJ, JOHNSON RJ: Tubulointerstitial (TI) disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia, (abstract) J Am Soc Nephrol (in press)
55. EPSTEIN FH, AGMON Y, BREZIS M: Physiology of renal hypoxia. Ann NY Acad Sci 718:72-81, 1994
56. CARDILLO C, DE FELICE F, CAMPIA U, FOLLI G: Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension. Hypertension 21(6 Pt 1):836-44, 1993
57. CERASOLA G, COTTONE S, NARDI E, D'IGNOTO G, VOLPE V, MULE G, CAROLLO C: White-coat hypertension and cardiovascular risk. J Cardiovasc Risk 2:545-549, 1995
58. HØEGHOLM A, BANG L, KRISTENSEN K, NIELSEN J, HOLM J: Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 24:101-105, 1994
59. PICKERING T, JAMES G: Ambulatory blood pressure and prognosis. J Hypertens 12:S29-S33, 1994
60. FRATTOLA A, PARATI G, CUSPIDI C, ALBINI F, MANCIA G: Prognostic value of 24-hour blood pressure variability. J Hypertens 11:1133-1137, 1993
61. PARATI G, POMIDOSSI G, ALBINI F, MALASPINA D, MANCIA G: Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5:93-98, 1987
62. ENG E, VENIANT M, FLOEGE J, FINGERLE J, ALPERS CE, MENARD J, CLOZEL JP, JOHNSON RJ: Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens 7:177-185, 1994
63. MAI M, GEIGER H, HILGERS KF, VEELKEN R, MANN JF, DAMMRICH J, LUFT FC: Early interstitial changes in hypertension-induced renal injury. Hypertension 22:754-765, 1993
64. JOHNSON RJ, BIDANI A, ANDOH T, LOMBARDI D, GORDON K, GRIFFIN K, SCHREINER G, BENNETT WM: A role for the peritubular capillaries (PTC) and tubulointerstitium (TI) in the development of salt dependent hypertension. (abstract) J Am Soc Nephrol (in press)
65. KUROKAWA K: Kidney, salt, and hypertension: How and why. Kidney Int 49(Suppl 55):S46-S51, 1996
66. BACHMANN S, MUNDEL P: Nitric oxide in the kidney: Synthesis, localization, and function. Am J Kidney Dis 24:112-129, 1994
67. GOMEZ-ALAMILLO C, SANCHEZ-CASAJUS A, SIERRA M, HUARTE E, DIEZ J: Vasoconstriction of the afferent arteriole and defective renal synthesis of nitric oxide in essential hypertension. Kidney Int 49: S129-S131, 1996
68. GIACHELLI CM, PICHLER R, LOMBARDI D, DENHARDT DT, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
69. HWANG SM, LOPEZ CA, HECK DE, GARDNEK CR, LASKIN DL, LASKIN JD, DENHARDT DT: Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 269:711-715, 1994
70. PICHLER R, ANDOH T, HUGO C, SHANKLAND SJ, NANGAKU M, OPHASCHAROENSUK V, GIACHELLI C, ZACHEM C, ENG G, ALPERS CE, BENNETT WM, COUSER WG, JOHNSON RJ: Differential expression of nitric oxide synthase (NOS) isoforms in CSA nephropathy: Potential regulation by osteopontin (OPN). (abstract) J Am Soc Nephrol 7:1763, 1996
71. PICHLER RH, FRANCESCHINI N, YOUNG BA, HUGO C, ANDOH TF, BURDMANN EA, SHANKLAND SJ, ALPERS CE, BENNETT WM, COUSER WG, JOHNSON RJ: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
72. BARISONI L, RADHAKRISHNAN J, D'AGATI V: Osteopontin (OP) mRNA and protein expression in glomerular disease (GD) correlates with tubulo-interstitial damage (TID). (abstract) J Am Soc Nephrol 7:1751, 1996
73. EDDY AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. (editorial) J Am Soc Nephrol 5:1273-1287, 1994
74. BOUTARD V, HAVOUIS R, FOUOUERAY B, PHILIPPE C, MOULINOUX JP, BAUD L: Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J Immunol 155:2077-2084, 1995
75. MALYANKAR U, ALMEIDA M, JOHNSON R, PICHLER R, GIACHELLI C: Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int (in press)
76. KLEINMAN J, WORCESTER E, BESHENSKY A, SHERIDAN A, BONVENTRE J, BROWN D: Upregulation of osteopontin expression by ischemia in rat kidney. Ann NY Acad Sci 760:321-323, 1995
77. MATTSON DL, ROMAN RJ, COWLEY AW JR: Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension 19(6 Pt 2):766-769, 1992
78. MATTSON DL, LU S, NAKANISHI K, PAPANEK PE, COWLEY AW JR: Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol 266(5 Pt 2):H1918-H1926, 1994
79. MATTSON DL, BELLEHUMEUR TG: Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension 28:297-303, 1996
80. LAURANT P, DEMOLOMBE B, BERTHELOT A: Dietary L-arginine attenuates blood pressure in mineralocorticoid-salt hypertensive rats. Clin Exp Hypertens 17:1009-1024, 1995
81. HU L, MANNING RD JR: Role of nitric oxide in regulation of long-term pressure-natriuresis relationship in Dahl rats. Am J Physiol 268(6 Pt 2):H2375-H2383, 1995
82. MILLER WL, THOMAS RA, BERNE RM, RUBIO R: Adenosine production in the ischemic kidney. Circ Res 43:390-397, 1978
83. PALMER TM, STILES GL: Adenosine receptors. Neuropharmacology 34:683-694, 1995
84. SEALEY J, BLUMENFELD J, GORDON M, PECKER M, SOMMERS S, LARAGH J: On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. J Hypertens 6:763-777, 1988
85. VAN BUREN M, BIJLSMA JA, BOER P, VAN RIJN HJ, KOOMANS HA: Natriuretic and hypotensive effect of adenosine-1 blockade in essential hypertension. Hypertension 22:728-734, 1993
86. INGELFINGER JR, DZAU VJ: Molecular biology of renal injury: Emphasis on the role of the renin-angiotensin system. J Am Soc Nephrol 2(Suppl 1):S9-S20, 1991
87. LO M, LIU KL, LANTELME P, SASSARD J: Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest 95:1394-1397, 1995
88. WOLF G, MUELLER E, STAHL RA, ZIYADEH FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 92:1366-1372, 1993
89. ANDERSON S, OYAMA T, JUNG F, INGLEFINGER J: Renin-angiotensin system and the aging kidney. (abstract) J Am Soc Nephrol 5:937, 1994
90. CONVERSE RL JR, JACOBSEN TN, TOTO RD, JOST CM, COSENTINO F, FOUAD TARAZI F, VICTOR RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327:1912-1918, 1992
91. WINTERNITZ SR, KATHOLI RE, OPARIL S: Decrease in hypothalamic norepinephrine content following renal denervation in the one-kidney, one clip Goldblatt hypertensive rat. Hypertension 4:369-373, 1982
92. MATSUOKA H, NISHIDA H, NOMURA G, VAN VLIET BN, TOSHIMA H: Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 23(6 Pt 2):971-975, 1994
93. DIBONA GF: Renal neural mechanisms in salt-sensitive hypertension. Blood Press 2(Suppl):81-87, 1995
94. OSBORN J: Relation between sodium intake, renal function, and the regulation of arterial pressure. J Hypertension 17:191-196, 1991
95. KUCHEL O, BUU NT, UNGER T: Dopamine-sodium relationship: Is dopamine a part of the endogenous natriuretic system? Contrib Nephrol 13:27-36, 1978
96. WOOLFSON R, DE WARDENER H: Primary renal abnormalities in hereditary hypertension. Kidney Int 50:717-731, 1996
97. IIMURA O, SHIMAMOTO K: Salt and hypertension: Water-sodium handling in essential hypertension. Ann N Y Acad Sci 676:105-121, 1993
98. SCHNERMANN J, BRIGGS J: Restoration of tubuloglomerular feedback in volume-expanded rats by angiotensin II. Am J Physiol 259:F565-F572, 1990
99. DZAU V: Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol 22:S1-S9, 1993
100. HOLLENBERG NK, GRAVES SW: Koch's postulates and the digitalislike factor. Hypertens Res 18:1-6, 1995
101. MUIRHEAD EE: Renal vasodepressor mechanisms: The medullipin system. J Hypertens 5(Suppl):S53-S58, 1993 [published erratum appears in J Hypertens 12(4):H14, 1994]
102. LEBEL M, GROSE JH, BLAIS R: Abnormal relation of extracellular fluid volume and exchangeable sodium with systemic arterial pressure in early borderline essential hypertension. Am J Cardiol 54: 1267-1271, 1984
103. LONDON GM, LEVENSON JA, LONDON AM, SIMON AC, SAFAR ME: Systemic compliance, renal hemodynamics, and sodium excretion in hypertension. Kidney Int 26:342-350, 1984
104. SULLIVAN JM: Borderline hypertension and sodium sensitivity. J Cardiovasc Pharmacol 5(Suppl):S31-S35, 1986
105. OVERLACK A, RUPPERT M, KOLLOCH R, KRAFT K, STUMPE KO: Age is a major determinant of the divergent blood pressure responses to varying salt intake in essential hypertension. Am J Hypertens 8:829-836, 1995
106. PEDRINELLI R: Microalbuminuria in hypertension. Nephron 73:499-505, 1996
107. MUELLER PW, HALL WD, CAUDILL SP, MACNEIL ML, AREPALLY A: An in-depth examination of the excretion of albumin and other sensitive markers of renal damage in mild hypertension. Am J Hypertens 8:1072-1082, 1995
108. BIGAZZI R, BIANCHI S, BALDARI D, SGHERRI G, BALDARI G, CAMPESE VM: Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 23:195-199, 1994
109. UZU T, KAZEMBE FS, ISHIKAWA K, NAKAMURA S, INENAGA T, KIMURA G: High sodium sensitivity implicates nocturnal hypertension in essential hypertension. Hypertension 28:139-142, 1996
110. BIANCHI S, BIGAZZI R, BALDARI G, SGHERRI G, CAMPESE VM: Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 7:23-29, 1994
111. MIDDEKE M, SCHRADER J: Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. Brit Med J 308:630-632, 1994
112. BALD M, LETTGEN B, WINGEN A-M, BONZEL K: 24-hour blood pressure monitoring in children and adolescents after recovery from hemolytic uremic syndrome. Clin Nephrol 46:50-53, 1996
113. EKELUND I, SUCHINDRAN C, KARON J, MCMAHON R, TYROLER H: Black-white differences in exercise blood pressure: The Lipid Research Clinics program prevalence study. Circulation 31:1568-1574, 1990
114. DIMSDALE JE, GRAHAM RM, ZIEGLER MG, ZUSMAN RM, BERRY CC: Age, race, diagnosis, and sodium effects on the pressor response to infused norepinephrine. Hypertension 10:564-569, 1987
115. PARMER RJ, STONE RA, CERVENKA JH: Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium. Hypertension 24:752-757, 1994
116. WEINBERGER MH: Hypertension in African Americans: The role of sodium chloride and extracellular fluid volume. Semin Nephrol 16:110-116, 1996
117. DARMADY EM, OFFER J, WOODHOUSE MA: The parameters of the ageing kidney. J Pathol 109:195-207, 1973
118. LIANG CT, BARNES J: Renal expression of osteopontin and alkaline phosphatase correlates with BUN levels in aged rats. Am J Physiol 269(3 Pt 2):F398-F404, 1995
119. SOWERS JR, WHITFIELD LA, CATANIA RA, STERN N, TUCK ML, DORNFELD L, MAXWELL M: Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab 54(6):1181-1186, 1982
120. MUELLER S, BROWN G: Hourly rhythms in blood pressure in persons with normal and elevated pressures. Ann Intern Med 3:1190-1200, 1930
121. STOKHOLM KH, BROCHNER MORTENSEN J, HOILUND CARLSEN PF: Increased glomerular filtration rate and adrenocortical function in obese women. Int J Obes 4:57-63, 1980
122. KASISKE BL, CROSSON JT: Renal disease in patients with massive obesity. Arch Intern Med 146:1105-1109, 1986
123. RAISON J, ACHIMASTOS A, ASMAR R, SIMON A, SAFAR M: Extracellular and interstitial fluid volume in obesity with and without associated systemic hypertension. Am J Cardiol 57:223-226, 1986
124. ROCCHINI AP, KEY J, BONDIE D, CHICO R, MOOREHEAD C, KATCH V, MARTIN M: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321:580-585, 1989
125. MARUMO T, NAKAKI T, HISHIKAWA K, SUZUKI H, KATO R, SARUTA T: Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension 25(4 Pt 2):764-768, 1995
126. ROSEN S, GREENFELD Z, BREZIS M: Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury. Transplantation 49:445-452, 1990
127. BENNETT W, DEMATTOS A, MEYER M, ANDOH T, BARRY J: Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 50:1089-1100, 1996
128. LE Q, DAVIS C, GIACHELLI C, JOHNSON R, HUDKINS K, ALPERS C: Osteopontin expression in renal transplant biopsies. (abstract) Lab Invest 70:158, 1994
129. PANKEWYCZ O, MIAO L, ISAACS R, GUAN J, PRUETT T, HAUSSMANN G, STURGILL BC: Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Kidney Int 50:1634-1640, 1996
130. CURTIS JJ, LUKE RG, JONES P, DIETHELM AG: Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent. [see comments] Am J Med 85:134-138, 1988
131. TAKAZAKURA E, SAWABU N, HANDA A, TAKADA A, SHINODA A, TAKEUCHI J: Intrarenal vascular changes with age and disease. Kidney Int 2:224-230, 1972
132. MUTER E, NATH K: Chronic tubulointerstitial nephritis, in The Principles and Practice of Nephrology, edited by JACOBSON H, STRIKER G, KLAHR S, St. Louis, Mosby Yearbook Press, 1995, pp 216-223
133. KUSTER G, RITZ E: Analgesic abuse and hypertension. (letter) Lancet 2:1105, 1989
134. ROMAN RJ, KALDUNSKI ML: Renal cortical and papillary blood flow in spontaneously hypertensive rats. Hypertension 11(6 Pt 2):657-663, 1988
135. MACKENZIE H, LAWLER E, BRENNER B: Pathogenesis and pathophysiology of essential hypertension. Congenital oligonephropathy: The fetal flaw in essential hypertension? Kidney Int 49:S30-S34, 1996